|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
channel subunit in rodents1 Nephrology/Hypertension Division, Franz Volhard Clinic, HELIOS Klinikum-Berlin, Campus Buch, Berlin, Germany 2 Medical Faculty of the Charité, Nephrology/Intensive Care Division, Campus Virchow, Berlin, Germany 3 Max Delbrück Center for Molecular Medicine, Campus Buch, Berlin, Germany 4 Department of Biochemistry and Pharmacology, University of Texas Southwestern Medical Center, Dallas, TX, USA 5 Department of Pharmacology and Toxicology, Institute of Pharmacy, University of Tübingen, Tübingen, Germany
17,18-Epoxyeicosatetraenoic acid (17,18-EETeTr) stimulates vascular large-conductance K+ (BK) channels. BK channels are composed of the pore-forming BK
and auxiliary BK β1 subunits that confer an increased sensitivity for changes in membrane potential and calcium to BK channels. Ryanodine-sensitive calcium-release channels (RyR3) in the sarcoplasmic reticulum (SR) control the process. To elucidate the mechanism of BK channel activation, we performed whole-cell and perforated-patch clamp experiments in freshly isolated cerebral and mesenteric artery vascular smooth muscle cells (VSMC) from Sprague–Dawley rats, BK β1 gene-deficient (–/–), BK
(–/–), RyR3 (–/–) and wild-type mice. The 17,18-EETeTr (100 nM) increased tetraethylammonium (1 mM)-sensitive outward K+ currents in VSMC from wild-type rats and wild-type mice. The effects were not inhibited by the epoxyeicosatrienoic acid (EET) antagonist 14,15-epoxyeicosa-5(Z)-enoic acid (10 µM). BK channel currents were increased 3.5-fold in VSMC from BK β1 (–/–) mice, whereas a 2.9-fold stimulation was observed in VSMC from RyR3 (–/–) mice (at membrane voltage 60 mV). The effects were similar compared with those observed in cells from wild-type mice. The BK current increase was neither influenced by strong internal calcium buffering (Ca2+, 100 nM), nor by external calcium influx. The 17,18-EETeTr did not induce outward currents in VSMC BK
(–/–) cells. We next tested the vasodilator effects of 17,18-EETeTr on isolated arteries of BK
-deficient mice. Vasodilatation was largely inhibited in cerebral and mesenteric arteries isolated from BK
(–/–) mice compared with that observed in wild-type and BK β1 (–/–) arteries. We conclude that 17,18-EETeTr represents an endogenous BK channel agonist and vasodilator. Since 17,18-EETeTr is active in small arteries lacking BK β1, the data further suggest that BK
represents the molecular target for the principal action of 17,18-EETeTr. Finally, the action of 17,18-EETeTr is not mediated by changes of the internal global calcium concentration or local SR calcium release events.
(Received 18 April 2007;
accepted after revision 20 July 2007; first published online 3 August 2007)
Corresponding author M. Gollasch: Charité University Medicine, Nephrology and Intensive Care, Augustenburger Platz 1, 13353 Berlin, Germany. Email: maik.gollasch{at}charite.de
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |